Please assess the completion status of the following clinical trial:

Trial Title: Blood Vessel Function in Adolescents and Women With Polycystic Ovary Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* PCOS as defined by NIH/NICHD criteria: 1) oligo- or amenorrhea (≤8 menstrual periods annually, persisting 2 years post menarche); 2) biochemical hyperandrogenism(HA), i.e.,elevated total or free testosterone concentration and/or clinical evidence of HA (defined as the presence of hirsutism); and 3) exclusion of secondary causes of ovulatory dysfunction and HA (including hyperprolactinemia, thyroid dysfunction, non-classical congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency, Cushing syndrome, androgen secreting neoplasms, and androgenic/anabolic drug use).~* Inclusion criteria for adolescent and adult control subjects will include 1) normal menstrual periods (defined as regular cycles between 22-36 days in length); 2) normal serum androgens (total/free testosterone and dehydroepiandrosterone-sulfate \[DHEA-S\]); and 3) absence of clinical evidence of hyperandrogenism. Additionally, adolescent controls must be 2 years post menarche.~Exclusion Criteria:~* Diabetes mellitus~* Underlying endocrine, neurologic, and/or genetic syndromes leading to obesity~* Congenital heart disease or abnormal resting ECG~* Renal or hepatic disease~* History of rheumatologic disorders or malignancy~* Use of medications or dietary supplements known to affect insulin sensitivity (i.e. metformin, corticosteroids, and oral contraceptive pills), blood pressure, or cholesterol within 3 months of study participation~* Investigation drug use within 3 months of study participation~* Pregnancy~* Current tobacco use

- Gender: FEMALE
- Minimum Age: 14 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- PCOS adolescents (Type: None): Post-menarchal females ages 14-17 with and without PCOS (15 each group for a total of 30 subjects).
- PCOS women (Type: None): Women ages 18-40 with and without PCOS (15 each group for a total of 30 subjects).

Based on this trial design, predict the completion outcome and termination type (if applicable).